Prettybrook Partners
  • Home
    • Privacy Policy
  • About
  • Team
  • Strategy
  • Investments
  • News
  • Contact
Select Page
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company

Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company

by TechBear | Jan 6, 2023 | News

Orthofix and SeaSpine Stockholders Approve Merger LEWISVILLE, Texas, January 04, 2023 – (BUSINESS WIRE) – Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger...
Orthofix, SeaSpine plan all-stock merger to create global spine and orthopedic company

Orthofix, SeaSpine plan all-stock merger to create global spine and orthopedic company

by TechBear | Oct 14, 2022 | News

Orthofix (Nasdaq:OFIX) and SeaSpine (Nasdaq:SPNE) today announced a definitive agreement to combine companies in an all-stock merger of equals. Under the terms of the agreement, SeaSpine shareholders will receive 0.4163 shares of Orthofix common stock for each share...
Availity to Acquire Diameter Health, a Leader in Clinical Data Interoperability

Availity to Acquire Diameter Health, a Leader in Clinical Data Interoperability

by TechBear | Aug 29, 2022 | News

Joint technology solution will deliver an integrated data interoperability platform that streamlines data acquisition and delivers clean, actionable, and intelligent data. JACKSONVILLE, Fla., Aug. 9, 2022 /PRNewswire/ — Availity, one of the nation’s...
Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

by TechBear | Aug 29, 2022 | News

NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood...
Amarin Announces Appointment of New Directors and Board Leadership Changes

Amarin Announces Appointment of New Directors and Board Leadership Changes

by TechBear | May 20, 2022 | News

Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company’s Strategy Per Wold-Olsen Named Chairman of the Board David Stack and Joe Zakrzewski to Retire from the Board Actions...
« Older Entries

Recent Posts

  • Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
  • Orthofix, SeaSpine plan all-stock merger to create global spine and orthopedic company
  • Availity to Acquire Diameter Health, a Leader in Clinical Data Interoperability
  • Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors
  • Amarin Announces Appointment of New Directors and Board Leadership Changes

Categories

  • Latest
  • News
TechBearPowered by TechBear

Copyright All Rights Reserved Prettybrook Partners © 2023